Eingeschlossene Patienten: 23.062 (Stand 01. Oktober 2024)
Amgevita® (Adalimumab)
232
Benepali® (Etanercept)
1226
Cimzia® (Certolizumab)
1035
Enbrel® (Etanercept)
2872
Erelzi® (Etanercept)
559
Flixabi® (Infliximab)
10
Hukyndra® (Adalimumab)
7
Hulio® (Adalimumab)
255
Humira® (Adalimumab)
2910
Hyrimoz® (Adalimumab)
234
Idacio® (Adalimumab)
63
Imraldi® (Adalimumab)
226
Inflectra™ (Infliximab)
17
Jyseleca® (Filgotinib)
148
Kevzara® (Sarilumab)
223
Kineret® (Anakinra)
89
MabThera® (Rituximab)
1459
Nepexto® (Etanercept)
89
Olumiant® (Baricitinib)
545
Orencia® (Abatacept)
985
Remicade® (Infliximab)
762
Remsima® (Infliximab)
25
Rinvoq® (Upadacitinib)
310
Rixathon® (Rituximab)
20
RoActemra® (Tocilizumab)
1377
Ruxience® (Rituximab)
1
Simponi® (Golimumab)
471
Truxima® (Rituximab)
2
Tyenne® (Tocilizumab)
29
Xeljanz® (Tofacitinib)
396
Yuflyma® (Adalimumab)
42
Zessly® (Infliximab)
2
Kontrollen
6441
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok